The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

A larger Phase 3 clinical trial will have to ultimately validate ... the longest surviving people previously diagnosed with stage 4 melanoma, the most advanced form of the disease.

X4 Pharmaceuticals (XFOR) announced positive new clinical data from its now completed Phase 2 clinical trial evaluating mavorixafor, an oral ...

A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess ™) for frown ...

The subset of participants with congenital neutropenia (n=4 of 9) also had mean percentage of functional ... s confidence in achieving success in the ongoing pivotal Phase 3 4WARD clinical trial.

I know this is a Phase Four list, but her joining forces with Captain Marvel and Monica Rambeau in The Marvels is one you have to see! 8 of 18 'Black Widow' (2021) ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

The Phase III programme is expected to begin by the end of 2024 and is aiming to include a minimum of 1,800 patients.

1,10 Results demonstrate the long-term safety of repeated RelabotulinumtoxinA injections, consistent with the safety profile observed in the phase III READY-1, -2 and -3 clinical trials.1,4,9,11 ...